Evidence-based articles on biohacking, AI research and substances — anchored in real PubMed studies.
NMN, NR, and Nicotinamid sometimes reliably raise NAD+ markers; however, clinical effects on sleep, insulin sensitivity, and muscle function remain limited so far.
Read moreHow well do Semaglutide and Tirzepatide work long term, what happens after stopping, and how large is the risk of muscle loss? Overview with evidence, limits, and practical takeaways.
Read moreBerberine lowers blood sugar and HbA1c moderately in studies, but the evidence is heterogeneous. Here: evidence base, dosage, risks, and comparison with metformin.
Read more